You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPN-SAF

Showing 1 - 25 of 164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Myeloproliferative Tumor Trial in Irvine (Diet intervention)

Completed
  • Myeloproliferative Neoplasm
  • Diet intervention
  • Irvine, California
    University of California, Irvine
Jun 16, 2022

Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

Enrolling by invitation
  • Thrombocythemia, Essential
  • Primary Myelofibrosis
  • Miami, Florida
  • +18 more
Jan 30, 2023

Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

Not yet recruiting
  • Bone Marrow Fibrosis
  • Myeloproliferative Neoplasm
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023

Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

Completed
  • Primary Myelofibrosis
  • Anemia
  • Phoenix, Arizona
  • +24 more
Aug 17, 2022

Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

Enrolling by invitation
  • Myelodysplastic/Myeloproliferative Neoplasms
  • Adult
  • venetoclax combined with azacitidine
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Mar 7, 2022

Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Jun 15, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

Myeloid Diseases Trial (DFV890)

Not yet recruiting
  • Myeloid Diseases
  • (no location specified)
Nov 11, 2022

Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

Not yet recruiting
  • Myeloproliferative Disorders
  • Leukemia
  • Cardiac Lifestyle Program
  • Boston, Massachusetts
  • +2 more
May 1, 2023

A Prospective, Non-interventional Study of JAKAVI® Treatment in

Active, not recruiting
  • Polycythemia Vera
  • Jakavi
  • Reutlingen, Baden Wuerttemberg, Germany
  • +98 more
May 16, 2023

Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Moderate and High Risk Myelofibrosis Trial in China (TQ05105 tablets, Hydroxycarbamide tablets)

Recruiting
  • Moderate and High Risk Myelofibrosis
  • TQ05105 tablets
  • Hydroxycarbamide tablets
  • Beijing, Beijing, China
  • +3 more
Nov 23, 2021

Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

Recruiting
  • Myeloproliferative Neoplasms
  • Herston, Queensland, Australia
  • +22 more
Jun 30, 2023

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)

Recruiting
  • Phlebotomy Dependent Polycythemia Vera
  • Orange, California
  • +4 more
Aug 1, 2022

Myeloproliferative Tumor Trial in New York (Vactosertib)

Recruiting
  • Myeloproliferative Neoplasm
  • New York, New York
    Weill Medical College of Cornell University
Dec 20, 2021

Myeloproliferative Disorder, Aquagenic Pruritus Trial in France (Aprepitant 80 mg, Hydroxyzine 25mg, Placebo of Hydroxyzine)

Recruiting
  • Myeloproliferative Disorder
  • Aquagenic Pruritus
  • Aprepitant 80 mg
  • +3 more
  • Brest, Brest Cedex, France
  • +10 more
Jun 10, 2021